Literature DB >> 36186916

Molecular Targeted Therapy Approach to Musculoskeletal Tumors.

Izuchukwu Ibe1, Monique Haynes1, Andrew Koo1, Dieter Lindskog1, Gary E Friedlaender1, Francis Y Lee1.   

Abstract

The future of cancer treatment is promising. Although marred by years of plateau in outcomes, new avenues have been identified that are poised to change how we treat cancer. Molecular targeted therapy or targeted therapy is one of these methods. Molecular targeted therapy involves identifying specific pathways or markers that allow cancer cells to flourish. Once identified, specific molecules can be used to block proliferative pathways, thereby negatively impacting tumor growth. Targeting specific pathways that prolong the survival of the cancer cell can lead to a decreased cancer burden, and improved patient outcomes. This article reviews the tenets of molecular targeted therapy, common pathways, target acquisition for drug development, and the pathways that have been elucidated in musculoskeletal tumors.

Entities:  

Year:  2018        PMID: 36186916      PMCID: PMC9524233          DOI: 10.1097/bto.0000000000000298

Source DB:  PubMed          Journal:  Tech Orthop


  23 in total

1.  Dynamics of targeted cancer therapy.

Authors:  Ivana Bozic; Benjamin Allen; Martin A Nowak
Journal:  Trends Mol Med       Date:  2012-05-15       Impact factor: 11.951

Review 2.  Molecularly targeted cancer therapy: some lessons from the past decade.

Authors:  Min Huang; Aijun Shen; Jian Ding; Meiyu Geng
Journal:  Trends Pharmacol Sci       Date:  2013-12-19       Impact factor: 14.819

Review 3.  Molecular imaging in drug development: Update and challenges for radiolabeled antibodies and nanotechnology.

Authors:  Ilaria Colombo; Marta Overchuk; Juan Chen; Raymond M Reilly; Gang Zheng; Stephanie Lheureux
Journal:  Methods       Date:  2017-07-23       Impact factor: 3.608

Review 4.  The role of PTEN signaling perturbations in cancer and in targeted therapy.

Authors:  M Keniry; R Parsons
Journal:  Oncogene       Date:  2008-09-18       Impact factor: 9.867

Review 5.  The MAPK pathway across different malignancies: a new perspective.

Authors:  Mauricio Burotto; Victoria L Chiou; Jung-Min Lee; Elise C Kohn
Journal:  Cancer       Date:  2014-06-19       Impact factor: 6.860

Review 6.  Targeting RAS signalling pathways in cancer therapy.

Authors:  Julian Downward
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

Review 7.  Targeted therapies in breast cancer: are heart and vessels also being targeted?

Authors:  Carmen Criscitiello; Otto Metzger-Filho; Kamal S Saini; Gilberto de Castro; Marie Diaz; André La Gerche; Evandro de Azambuja; Martine J Piccart-Gebhart
Journal:  Breast Cancer Res       Date:  2012-06-19       Impact factor: 6.466

Review 8.  Immunotherapy for Bone and Soft Tissue Sarcomas.

Authors:  Takenori Uehara; Tomohiro Fujiwara; Ken Takeda; Toshiyuki Kunisada; Toshifumi Ozaki; Heiichiro Udono
Journal:  Biomed Res Int       Date:  2015-06-17       Impact factor: 3.411

Review 9.  A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research.

Authors:  Sara S Faria; Carlos F M Morris; Adriano R Silva; Micaella P Fonseca; Patrice Forget; Mariana S Castro; Wagner Fontes
Journal:  Front Oncol       Date:  2017-02-20       Impact factor: 6.244

Review 10.  The dynamic nature of the kinome.

Authors:  Lee M Graves; James S Duncan; Martin C Whittle; Gary L Johnson
Journal:  Biochem J       Date:  2013-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.